Literature DB >> 19631201

An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D.

Dennis Wagner1, Heather E C Hanwell, Reinhold Vieth.   

Abstract

OBJECTIVES: To compare two new automated assays with the well-established reference method, DiaSorin radioimmunoassay (RIA), for quantitation of serum total 25-hydroxyvitamin D [25(OH)D].
METHODS: 25(OH)D from human sera (n=158) was measured using DiaSorin RIA and two automated platforms, DiaSorin "LIAISON 25 OH Vitamin D TOTAL", and Roche Modular "Vitamin D3 (25-OH)". Methods were compared by regression and Bland-Altman analyses.
RESULTS: DiaSorin LIAISON demonstrated a stronger correlation (r=0.918) and better agreement (bias=-0.88 nmol/L) with DiaSorin RIA than the Roche Modular assay (r=0.871, bias=-2.55 nmol/L). Precision ranges (CV%) for the RIA, LIAISON, and Roche Modular assays, respectively, were: within run (6.8-12.9%, 2.8-8.1%, and 1.9-5.5%), and total precision (7.4-14.5%, 7.3-17.5%, and 7.6-14.5%).
CONCLUSION: DiaSorin LIAISON displayed the best correlation and agreement with DiaSorin RIA. The DiaSorin LIAISON 25 OH Vitamin D TOTAL assay is an accurate and precise automated tool for serum total 25(OH)D determination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631201     DOI: 10.1016/j.clinbiochem.2009.07.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  84 in total

1.  Model-based meta-analysis for development of a population-pharmacokinetic (PPK) model for Vitamin D3 and its 25OHD3 metabolite using both individual and arm-level data.

Authors:  Alanna S Ocampo-Pelland; Marc R Gastonguay; Jonathan F French; Matthew M Riggs
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-02-12       Impact factor: 2.745

2.  Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Stephanie J Weinstein; Mark P Purdue; Stephanie A Smith-Warner; Alison M Mondul; Amanda Black; Jiyoung Ahn; Wen-Yi Huang; Ronald L Horst; William Kopp; Helen Rager; Regina G Ziegler; Demetrius Albanes
Journal:  Int J Cancer       Date:  2014-09-02       Impact factor: 7.396

3.  Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats.

Authors:  Akihiro Shimomura; Isao Matsui; Takayuki Hamano; Takuya Ishimoto; Yumiko Katou; Kenji Takehana; Kazunori Inoue; Yasuo Kusunoki; Daisuke Mori; Chikako Nakano; Yoshitsugu Obi; Naohiko Fujii; Yoshitsugu Takabatake; Takayoshi Nakano; Yoshiharu Tsubakihara; Yoshitaka Isaka; Hiromi Rakugi
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

4.  Low Dietary Intake of Vitamin D and Vitamin D Deficiency in Hemodialysis Patients.

Authors:  Maria Krassilnikova; Katya Ostrow; Amanda Bader; Peter Heeger; Anita Mehrotra
Journal:  J Nephrol Ther       Date:  2014-05-15

5.  Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype.

Authors:  Yasuo Kusunoki; Isao Matsui; Takayuki Hamano; Akihiro Shimomura; Daisuke Mori; Sayoko Yonemoto; Yoshitsugu Takabatake; Yoshiharu Tsubakihara; René St-Arnaud; Yoshitaka Isaka; Hiromi Rakugi
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

6.  Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel.

Authors:  Kassandra L Munger; Lynn I Levin; Jennifer Massa; Ronald Horst; Tihamer Orban; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2013-02-03       Impact factor: 4.897

7.  Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.

Authors:  Anthony A Portale; Myles S Wolf; Shari Messinger; Farzana Perwad; Harald Jüppner; Bradley A Warady; Susan L Furth; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-25       Impact factor: 8.237

8.  25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).

Authors:  Katherine Van Loon; Kouros Owzar; Chen Jiang; Hedy L Kindler; Mary F Mulcahy; Donna Niedzwiecki; Eileen M O'Reilly; Charles Fuchs; Federico Innocenti; Alan P Venook
Journal:  J Natl Cancer Inst       Date:  2014-08-06       Impact factor: 13.506

9.  Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Wei Zheng; Kim N Danforth; Shelley S Tworoger; Marc T Goodman; Alan A Arslan; Alpa V Patel; Marjorie L McCullough; Stephanie J Weinstein; Laurence N Kolonel; Mark P Purdue; Xiao-Ou Shu; Kirk Snyder; Emily Steplowski; Kala Visvanathan; Kai Yu; Anne Zeleniuch-Jacquotte; Yu-Tang Gao; Susan E Hankinson; Chinonye Harvey; Richard B Hayes; Brian E Henderson; Ronald L Horst; Kathy J Helzlsouer
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

10.  Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Marjorie L McCullough; Stephanie J Weinstein; D Michal Freedman; Kathy Helzlsouer; W Dana Flanders; Karen Koenig; Laurence Kolonel; Francine Laden; Loic Le Marchand; Mark Purdue; Kirk Snyder; Victoria L Stevens; Rachael Stolzenberg-Solomon; Jarmo Virtamo; Gong Yang; Kai Yu; Wei Zheng; Demetrius Albanes; Jason Ashby; Kimberly Bertrand; Hui Cai; Yu Chen; Lisa Gallicchio; Edward Giovannucci; Eric J Jacobs; Susan E Hankinson; Patricia Hartge; Virginia Hartmuller; Chinonye Harvey; Richard B Hayes; Ronald L Horst; Xiao-Ou Shu
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.